Pierre Gravier is CHIEF FINANCIAL OFFICER of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 53,531 shares of PTCT, which is worth approximately $2.42 Million. The most recent transaction as insider was on Jul 16, 2024, when has been sold 2,269 shares (Common Stock) at a price of $34.02 per share, resulting in proceeds of $77,191. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.5K
0% 3M change
58.85% 12M change
Total Value Held $2.42 Million

Pierre Gravier Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 16 2024
SELL
Open market or private sale
$77,191 $34.02 p/Share
2,269 Reduced 4.07%
53,531 Common Stock
Feb 15 2024
BUY
Grant, award, or other acquisition
-
22,100 Added 28.37%
55,800 Common Stock
Dec 12 2023
BUY
Open market or private purchase
$198,737 $25.81 p/Share
7,700 Added 18.6%
33,700 Common Stock
Jul 13 2023
BUY
Grant, award, or other acquisition
-
26,000 Added 50.0%
26,000 Common Stock

Also insider at

SAVA
CASSAVA SCIENCES INC Healthcare
PG

Pierre Gravier

CHIEF FINANCIAL OFFICER
South Plainfield, NJ

Track Institutional and Insider Activities on PTCT

Follow PTC THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT